These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Relation of endothelial cell function to erectile dysfunction: implications for treatment. Guay AT Am J Cardiol; 2005 Dec; 96(12B):52M-56M. PubMed ID: 16387568 [TBL] [Abstract][Full Text] [Related]
24. The association between erectile dysfunction and cardiovascular risk in men with Type 2 diabetes in primary care: it is a matter of age. Cleveringa FG; Meulenberg MG; Gorter KJ; van den Donk M; Rutten GE J Diabetes Complications; 2009; 23(3):153-9. PubMed ID: 18413203 [TBL] [Abstract][Full Text] [Related]
25. [Clinical and diagnostic approach to erectile dysfunction]. Foresta C; Argiolas A; Bassi P; Bettocchi C; Fabbri A; Gentile V; Ghirlanda G; Isidori A; Jannini E; Ledda A; Maggi M; Rosano GM; Spera G; Caretta N Ann Ital Med Int; 2003; 18(4):204-18. PubMed ID: 14971709 [TBL] [Abstract][Full Text] [Related]
26. A systematic approach to erectile dysfunction in the cardiovascular patient: a consensus statement. Jackson G; Betteridge J; Dean J; Hall R; Holdright D; Holmes S; Kirby M; Riley A; Sever P Int J Clin Pract; 1999 Sep; 53(6):445-51. PubMed ID: 10622072 [TBL] [Abstract][Full Text] [Related]
27. The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease. Grover SA; Lowensteyn I; Kaouache M; Marchand S; Coupal L; DeCarolis E; Zoccoli J; Defoy I Arch Intern Med; 2006 Jan; 166(2):213-9. PubMed ID: 16432091 [TBL] [Abstract][Full Text] [Related]
28. Erectile dysfunction: pathophysiologic mechanisms pointing to underlying cardiovascular disease. Ganz P Am J Cardiol; 2005 Dec; 96(12B):8M-12M. PubMed ID: 16387559 [TBL] [Abstract][Full Text] [Related]
29. Erectile dysfunction: cardiovascular risk and the role of the cardiologist. Solomon H; Man J; Wierzbicki AS; O'Brien T; Jackson G Int J Clin Pract; 2003 Mar; 57(2):96-9. PubMed ID: 12661790 [TBL] [Abstract][Full Text] [Related]
30. Phosphodiesterase type 5 inhibitor therapy: identifying and exploring what attributes matter more to clinicians and patients in the management of erectile dysfunction. Axilrod AC Curr Med Res Opin; 2007 Dec; 23(12):3189-98. PubMed ID: 17991309 [TBL] [Abstract][Full Text] [Related]
31. Phosphodiesterase-5 inhibitors for lower urinary tract symptoms in men. Gales BJ; Gales MA Ann Pharmacother; 2008 Jan; 42(1):111-5. PubMed ID: 18094344 [TBL] [Abstract][Full Text] [Related]
32. Sexual function in hypertensive patients receiving treatment. Reffelmann T; Kloner RA Vasc Health Risk Manag; 2006; 2(4):447-55. PubMed ID: 17323599 [TBL] [Abstract][Full Text] [Related]
33. [Etiology and management of erectile dysfunction in patients with diabetes mellitus]. Phé V; Rouprêt M; Ferhi K; Traxer O; Haab F; Beley S Prog Urol; 2009 Jun; 19(6):364-71. PubMed ID: 19467454 [TBL] [Abstract][Full Text] [Related]
34. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study. Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960 [TBL] [Abstract][Full Text] [Related]
35. Erectile dysfunction as a harbinger for increased cardiometabolic risk. Billups KL; Bank AJ; Padma-Nathan H; Katz SD; Williams RA Int J Impot Res; 2008; 20(3):236-42. PubMed ID: 18200018 [TBL] [Abstract][Full Text] [Related]
36. Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk. Nehra A; Jackson G; Miner M; Billups KL; Burnett AL; Buvat J; Carson CC; Cunningham GR; Goldstein I; Guay AT; Hackett G; Kloner RA; Kostis J; Montorsi P; Ramsey M; Rosen RC; Sadovsky R; Seftel AD; Vlachopoulos C; Wu FC J Urol; 2013 Jun; 189(6):2031-8. PubMed ID: 23313195 [TBL] [Abstract][Full Text] [Related]
37. Efficacy and limits of sildenafil citrate in patients with arterial erectile dysfunction: role of peripheral arterial disease and cardiovascular comorbidities. Vicari E; Malaguarnera M; La Vignera S; Calzavara F; Battiato C; Calogero AE Asian J Androl; 2008 Nov; 10(6):847-53. PubMed ID: 18958348 [TBL] [Abstract][Full Text] [Related]
38. Diagnosis and management of erectile dysfunction in the primary care setting. Rosenberg MT Int J Clin Pract; 2007 Jul; 61(7):1198-208. PubMed ID: 17577299 [TBL] [Abstract][Full Text] [Related]
39. The relationship between erectile dysfunction and cardiovascular disease. Part I: pathophysiology and mechanisms. Kapur V; Schwarz ER Rev Cardiovasc Med; 2007; 8(4):214-9. PubMed ID: 18192944 [TBL] [Abstract][Full Text] [Related]
40. Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus. Jackson G; Boon N; Eardley I; Kirby M; Dean J; Hackett G; Montorsi P; Montorsi F; Vlachopoulos C; Kloner R; Sharlip I; Miner M Int J Clin Pract; 2010 Jun; 64(7):848-57. PubMed ID: 20584218 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]